All In Biotech

Free tool

FAERS Monitor: Minocin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050649 or its brand name (Minocin, Minocycline Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,244

Serious

4,626

88% of reports

Hospitalization

2,522

Death reported

1,747

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,318
  • off label use1,216
  • drug intolerance988
  • pain948
  • rheumatoid arthritis946
  • nausea829
  • rash819
  • arthralgia812
  • drug hypersensitivity798
  • joint swelling762
  • fatigue758
  • condition aggravated711
  • general physical health deterioration705
  • pneumonia702
  • c-reactive protein increased697

Reports by year received

View as table
YearReports
200491
200579
200656
2007111
200892
200973
201066
2011106
2012146
201379
201477
2015117
2016179
2017214
2018256
2019284
2020320
2021238
2022392
2023417
2024723
2025794
2026334

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,915 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
c-reactive protein increasedSignal69778.373.052,192
drug intoleranceSignal98841.439.238,724
rheumatoid arthritisSignal94633.731.829,889
joint swellingSignal76225.523.817,882
general physical health deteriorationSignal70524.622.915,916
drug hypersensitivitySignal79816.615.611,746
condition aggravatedSignal7119.48.85,394
pneumoniaSignal7028.78.14,850
arthralgiaSignal8127.87.44,932
rashSignal8197.57.14,735
painSignal9486.25.94,245
off label useSignal1,2165.65.34,754
nauseaSignal8294.23.92,098
drug ineffectiveSignal1,3184.03.83,176
fatigueSignal7583.93.71,698

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.